Carbamic acid, ethyl ester → (S)-5-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-oxazolidin-2-one
Reaction equation
[C:1]([Si:5]([CH3:13])([CH3:12])[O:6][CH2:7][CH2:8][CH:9]1[CH2:11][O:10]1)([CH3:4])([CH3:3])[CH3:2].C([O:16][C:17](=O)[NH2:18])C.[N+](C1C=CC(C(O)=O)=CC=1)([O-])=O.[H-].[Na+]>>[C:1]([Si:5]([CH3:12])([CH3:13])[O:6][CH2:7][CH2:8][C@@H:9]1[O:10][C:17](=[O:16])[NH:18][CH2:11]1)([CH3:2])([CH3:3])[CH3:4]Participants
5
Procedure
Starting from 2-[2-[[(tert-butyl)dimethylsilyl]oxy]ethyl]-oxirane, (7.00 g; prepared according to WO 2007/144423), carbamic acid ethyl ester (1.46 g), 4-nitrobenzoic acid (347 mg), (R,R)-(salen)CoII complex (626 mg) and NaH (1.676 g) and proceeding in analogy to Org. Letters (2005), 7, 1983-1985, the title compound was obtained as a dark orange solid (880 mg; 11% yield).
Sources & evidence
- ORD record
- ord-bdd3a8fb9d6d4db9aa1e43d36e268d5c
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09346804B2
Reaction notes
Loading…